Cite
Systemic gene transfer of scAAV9.U1a.hSGSH for MPS IIIA: tolerability and preliminary evidence for a biochemical effect.
MLA
Flanigan, Kevin M., et al. “Systemic Gene Transfer of ScAAV9.U1a.HSGSH for MPS IIIA: Tolerability and Preliminary Evidence for a Biochemical Effect.” Molecular Genetics & Metabolism, vol. 120, no. 1/2, Jan. 2017, p. S47. EBSCOhost, https://doi.org/10.1016/j.ymgme.2016.11.098.
APA
Flanigan, K. M., Truxal, K. V., McBride, K. L., McNally, K. A., Kunkler, K. L., Zumberge, N. A., Martin, L., Aylward, S. C., Corridore, M., McKee, C., Fu, H., & McCarty, D. M. (2017). Systemic gene transfer of scAAV9.U1a.hSGSH for MPS IIIA: tolerability and preliminary evidence for a biochemical effect. Molecular Genetics & Metabolism, 120(1/2), S47. https://doi.org/10.1016/j.ymgme.2016.11.098
Chicago
Flanigan, Kevin M., Kristen V. Truxal, Kim L. McBride, Kelly A. McNally, Krista L. Kunkler, Nicholas A. Zumberge, Lisa Martin, et al. 2017. “Systemic Gene Transfer of ScAAV9.U1a.HSGSH for MPS IIIA: Tolerability and Preliminary Evidence for a Biochemical Effect.” Molecular Genetics & Metabolism 120 (1/2): S47. doi:10.1016/j.ymgme.2016.11.098.